Insider Selling: Ronda E. Stryker Unloads 21,000 Shares of Stryker Stock (SYK)
Stryker (NYSE:SYK) Director Ronda E. Stryker unloaded 21,000 shares of the stock in a transaction dated Friday, June 20th. The shares were sold at an average price of $85.21, for a total transaction of $1,789,410.00. Following the completion of the transaction, the director now directly owns 174,605 shares in the company, valued at approximately $14,878,092. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
Shares of Stryker (NYSE:SYK) traded up 0.51% during mid-day trading on Friday, hitting $86.08. 2,118,813 shares of the company’s stock traded hands. Stryker has a one year low of $63.71 and a one year high of $86.93. The stock’s 50-day moving average is $82.38 and its 200-day moving average is $79.45. The company has a market cap of $32.632 billion and a P/E ratio of 42.42.
Stryker (NYSE:SYK) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $1.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.09 by $0.03. The company had revenue of $2.31 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter in the previous year, the company posted $1.03 earnings per share. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. Analysts expect that Stryker will post $4.81 EPS for the current fiscal year.
SYK has been the subject of a number of recent research reports. Analysts at Argus upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research note on Wednesday, June 11th. They now have a $102.00 price target on the stock. Separately, analysts at Bernstein raised their price target on shares of Stryker from $84.00 to $89.00 in a research note on Wednesday, June 4th. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Stryker in a research note on Friday, April 25th. They now have a $82.00 price target on the stock. Eight investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $82.82.
Stryker Corporation (NYSE:SYK) is a medical technology company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.